Perspective Therapeutics Expands Management Team And Names Andrew Bright as Executive Vice-President of Brachytherapy

The appointment advances Perspective Therapeutics’ journey to become a global leader in the manufacturing and distribution of therapeutic Cesium-131 brachytherapy radioisotope seeds designed for the treatment of a variety of cancers.

Read more at globenewswire.com